ABT vs SYK
Abbott Laboratories (ABT) and Stryker (SYK) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $117.8B for Stryker, about 1.5 times the size. On trailing earnings, SYK is cheaper at 31.8x versus 38.6x for ABT.
Head to head
| Metric | ABT | SYK |
|---|---|---|
| Market cap | $179.4B | $117.8B |
| P/E (TTM) | 38.6x | 31.8x |
| Forward P/E | 17.4x | 18.4x |
| Revenue (TTM) | $48.2B | $25.8B |
| Revenue growth | 14.5% | 9.4% |
| Gross margin | 57.1% | 65.6% |
| Operating margin | 11.3% | 27.0% |
| Free cash flow | $7.4B | $4.7B |
| Dividend yield | 2.43% | 1.15% |
| 1-year return | -15.9% | -18.9% |
| 5-year return (annual) | -2.0% | +3.3% |
| Max drawdown | -46% | -59% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs SYK FAQ
Which is bigger, ABT or SYK?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $117.8B for Stryker, about 1.5 times the size.
Is ABT or SYK cheaper?
On trailing earnings, SYK is cheaper at 31.8x versus 38.6x for ABT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or SYK?
ABT returned -15.9% over the past year including dividends, versus -18.9% for SYK, through October 23, 2026.
Which pays a higher dividend, ABT or SYK?
ABT yields 2.43% versus 1.15% for SYK.
Full pages: Abbott Laboratories · Stryker